What does 2025 Hold for Biopharma? Insights and opportunities.
Full article published in: Citeline Each year, Scrip asks over 30 prominent biopharma executives, including our CEO, Liesbeth Ceelen, to gain insights on how funding, M&A, and partnerships are expected to shape the industry in the coming...
BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biotech Showcase during JP Morgan Week (Jan 13-15, 2025) in San...
BioLizard has been listed as a Trends Gazelle
As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025! This recognition is part of a joint initiative by Trends, Change the Game, and Kanaal Z, which closely monitors companies achieving the greatest growth based on value...